StockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD)

Research analysts at StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research note issued on Saturday. The firm set a “hold” rating on the stock.

TherapeuticsMD Stock Down 4.3 %

Shares of NASDAQ:TXMD opened at $1.99 on Friday. The stock’s 50-day moving average is $2.29 and its 200-day moving average is $2.37. TherapeuticsMD has a 52-week low of $1.95 and a 52-week high of $4.72.

Institutional Investors Weigh In On TherapeuticsMD

Several hedge funds and other institutional investors have recently made changes to their positions in TXMD. ADAR1 Capital Management LLC bought a new stake in shares of TherapeuticsMD in the fourth quarter valued at about $612,000. Clearline Capital LP lifted its stake in shares of TherapeuticsMD by 8.6% in the second quarter. Clearline Capital LP now owns 455,372 shares of the company’s stock valued at $1,876,000 after buying an additional 35,947 shares during the period. BlackRock Inc. lifted its stake in shares of TherapeuticsMD by 18.1% in the second quarter. BlackRock Inc. now owns 137,127 shares of the company’s stock valued at $565,000 after buying an additional 20,995 shares during the period. State Street Corp lifted its stake in shares of TherapeuticsMD by 13.6% in the first quarter. State Street Corp now owns 30,130 shares of the company’s stock valued at $113,000 after buying an additional 3,600 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of TherapeuticsMD by 22.2% in the first quarter. Geode Capital Management LLC now owns 81,781 shares of the company’s stock valued at $307,000 after buying an additional 14,835 shares during the period. 30.74% of the stock is owned by institutional investors and hedge funds.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors.